GLP-1 Side Effects: What to Expect and How to Manage Them

The most frequently reported side effects of GLP-1 medications are gastrointestinal: nausea, vomiting, diarrhea, constipation, and stomach discomfort. These occur because GLP-1 medications slow gastric emptying—food moves more slowly through the digestive system, which can cause discomfort especially early in treatment.

Nausea is the most common, affecting roughly 30–50% of users at some point during treatment. It's typically most pronounced during dose increases and usually improves significantly within a few weeks.

Fatigue is also reported by some users, particularly in the early weeks of treatment. This is often related to lower food intake and the body's adjustment to the medication.

GLP-1 side effects are strongly tied to the titration schedule. Most medications start at a low dose and increase gradually over weeks or months. Side effects tend to spike with each dose increase and then gradually improve.

The first 4–8 weeks are typically the most challenging, especially if the titration schedule moves quickly. Once patients reach a stable maintenance dose, side effects are generally much milder.

Eating too close to injection time, eating large meals, or eating high-fat foods can also trigger or worsen nausea. Injection timing and meal habits have a significant effect on tolerability.

Several practical strategies can significantly reduce gastrointestinal side effects. Eating smaller, lower-fat meals is one of the most effective. Large meals stretch the stomach, which is more uncomfortable when gastric emptying is slowed.

Injecting in the evening rather than the morning means the peak medication effect occurs while you sleep, which some users find reduces daytime nausea.

Staying well hydrated, eating slowly, and avoiding lying down immediately after eating can also help. If nausea is significant, your provider may recommend staying at the current dose longer before increasing.

Some users experience hair loss (telogen effluvium) associated with rapid weight loss rather than the medication itself. This is usually temporary and resolves as weight loss slows.

Muscle loss can accompany rapid weight loss on GLP-1 therapy. Ensuring adequate protein intake and including resistance exercise in your routine can help preserve muscle mass during treatment.

Headaches and dizziness are reported by some users, often related to eating less and caloric reduction rather than the medication directly.

Pancreatitis is a serious but uncommon risk associated with GLP-1 use. Symptoms include severe abdominal pain that may radiate to the back. If you experience this, stop the medication and seek medical care immediately.

Gallbladder problems, including gallstones, have been reported with GLP-1 medications, likely related to weight loss. Symptoms include upper abdominal pain, nausea, and fever.

GLP-1 medications carry a black box warning about thyroid C-cell tumors based on animal studies. This risk has not been confirmed in humans, but the medications are not recommended for people with a personal or family history of medullary thyroid carcinoma or MEN-2 syndrome.

Contact your telehealth provider or a medical professional if you experience: severe or persistent abdominal pain, signs of an allergic reaction (rash, swelling, difficulty breathing), vision changes, persistent vomiting that prevents you from eating or drinking, or symptoms of a low heart rate.

Most telehealth GLP-1 providers have a messaging system or support line for medication-related concerns. Use it—that's what it's there for.

Mild nausea, brief fatigue, and minor digestive changes are expected and don't typically require urgent intervention. Knowing the difference helps you manage the side effects that are manageable and escalate the ones that need attention.